Skip to Main

Search

Results 1 to 10 of 1,014 for ""

UT Southwestern No. 1 hospital in Dallas-Fort Worth, Best Hospital rankings show: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-us-news-best-hospital.html?utm_source=facebook&utm_medium=organic&utm_campaign=newsroom&utm_content=usnwrrankings&utm_utm-audience=na&fbclid=IwAR3tY4r24j2gT-WKC5ar4jpT51bBLwVrirgZfpXOMV_c4aSikMhT6vdPJaI

UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth – the nation’s fourth-largest metro area – for the sixth consecutive year and ranks among the top hospitals nationally in nine specialties ranging from brain to heart to cancer care.

Three drugs target resistant breast cancers driven by HER2 mutations

https://www.utsouthwestern.edu/newsroom/articles/year-2023/nov-triple-therapy-her2.html

A targeted therapy using three different drugs significantly delayed progression and extended survival for breast cancer patients whose HER2 gene is mutated.

UTSW builds AI-driven system to improve data collection : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/july-ai-model-speeds-medical-data-extraction.html

A multidisciplinary team at UT Southwestern Medical Center has developed an artificial intelligence (AI)-enabled pipeline that can quickly and accurately extract relevant information from complex, free-text medical records. The team’s novel approach, featured in npj Digital Medicine, could

Repurposed drug has promising efficacy in non-small cell lung cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-efficacy-non-small-cell-lung-cancer.html

An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) with KRAS mutations, a clinical trial led by UT Southwestern Harold C. Simmons Comprehensive Cancer Center researchers showed.

End-of-life care more aggressive for cancer patients with defibrillators: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/jan-end-of-life-care-more-aggressive-cancer-patients.html

Patients with advanced cancer who also had cardiac defibrillators were more likely than those without these implants to receive aggressive end-of-life care, a team led by UT Southwestern Medical Center researchers found in a new study.

All weight loss isn't equal for reducing heart failure risk : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/all-weight-loss-isnt-equal-for-reducing-heart-failure-risk.html

Reducing the level of body fat and waist size are linked to a lower risk of heart failure in patients with type 2 diabetes, a study led by UT Southwestern researchers indicates.

Scientists identify source of weight gain from antipsychotics: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/scientists-identify-source-of-weight-gain-from-antipsychotics.html

Scientists with UT Southwestern’s Peter O’Donnell Jr. Brain Institute have identified the molecular mechanism that can cause weight gain for those using a common antipsychotic medication.

Two studies shed light on how, where body can add new fat cells: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/where-body-can-add-new-fat-cells.html

Gaining more fat cells is probably not what most people want, although that might be exactly what they need to fight off diabetes and other diseases.

Tumor mutation associated with drug-resistant liver cancer, UT Southwestern study finds: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/june-tumor-mutation-drug-resistant-liver-cancer.html

A genetic marker discovered by UT Southwestern Medical Center researchers could help physicians predict which patients with hepatocellular carcinoma are most likely to develop resistance to the drug lenvatinib. The finding, published in the journal Gastroenterology, may lead to alternative

Children’s Research Institute at UT Southwestern discovers tumor growth fueled by nucleotide salvage: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/july-childrens-ut-tumor-growth-nucleotide-salvage.html

Cancer cells salvage purine nucleotides to fuel tumor growth, including purines in foods we eat, an important discovery with implications for cancer therapies from research by Children’s Medical Center Research Institute at UT Southwestern published in Cell.

Back-to top